Damian Williams, the United States Attorney for the Southern District of New York, Fernando McMillan, Special Agent in Charge of the New York Field Office of the US Food and Drug Administration’s Office of Criminal Investigations (“FDA-OCI”), and Daniel B. Brubaker, the Inspector in Charge of the New York Office of the US Postal Inspection Service (“USPIS”), announced today the unsealing of an Indictment charging Moses Rabinowitz, a/k/a “Mark Rabin,” and Menachim Samber with conspiracy to commit wire fraud and conspiracy to obtain pre-retail medical products by fraud or deception in connection with a scheme to obtain medical devices and over-the-counter (“OTC”) drugs not approved for sale in the US at discounted prices under the false pretense that they would be sold outside the US. Rabinowitz and Samber were arrested today and will be presented before US Magistrate Judge Victoria Reznick.
